Squarepoint’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
+20,908
| New | +$232K | ﹤0.01% | 2286 |
|
|
2024
Q4 | – | Sell |
-2,237
| Closed | -$42.3K | – | 3052 |
|
|
2024
Q3 | $42.3K | Buy |
+2,237
| New | +$42.3K | ﹤0.01% | 2443 |
|
|
2024
Q1 | – | Sell |
-5,700
| Closed | -$160K | – | 2717 |
|
|
2023
Q4 | $160K | Buy |
+5,700
| New | +$160K | ﹤0.01% | 2195 |
|
|
2022
Q3 | – | Sell |
-1,895
| Closed | -$130K | – | 2324 |
|
|
2022
Q2 | $130K | Buy |
+1,895
| New | +$130K | ﹤0.01% | 1834 |
|
|
2022
Q1 | – | Sell |
-968
| Closed | -$161K | – | 2590 |
|
|
2021
Q4 | $161K | Buy |
+968
| New | +$161K | ﹤0.01% | 2177 |
|
|
2021
Q3 | – | Sell |
-718
| Closed | -$342K | – | 2541 |
|
|
2021
Q2 | $342K | Sell |
718
-6,401
| -90% | -$3.05M | ﹤0.01% | 1871 |
|
|
2021
Q1 | $2.93M | Buy |
7,119
+33
| +0.5% | +$13.6K | 0.02% | 595 |
|
|
2020
Q4 | $3.47M | Buy |
7,086
+1,609
| +29% | +$788K | 0.03% | 524 |
|
|
2020
Q3 | $3.1M | Sell |
5,477
-454
| -8% | -$257K | 0.04% | 490 |
|
|
2020
Q2 | $565K | Buy |
5,931
+3,249
| +121% | +$310K | 0.01% | 1242 |
|
|
2020
Q1 | $191K | Sell |
2,682
-10,882
| -80% | -$775K | ﹤0.01% | 1482 |
|
|
2019
Q4 | $936K | Buy |
13,564
+10,889
| +407% | +$751K | 0.01% | 1342 |
|
|
2019
Q3 | $215K | Buy |
+2,675
| New | +$215K | ﹤0.01% | 1950 |
|
|
2018
Q3 | – | Sell |
-684
| Closed | -$118K | – | 2108 |
|
|
2018
Q2 | $118K | Buy |
+684
| New | +$118K | ﹤0.01% | 1625 |
|